ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2735

Association of a-Kinase Anchoring Protein-79 (AKAP79) to PKC Mediates Inhibition of IL2 Transcription and Erk Activation in T Cells

Gabriel Criado1, María J. Pérez-Lorenzo1, María Galindo2, Jose L. Pablos2 and Abel Suarez-Fueyo1, 1Grupo de Enfermedades Inflamatorias y Autoinmunes, Instituto de Investigación Hospital 12 de Octubre (I+12), Madrid, Spain, 2Servicio de Reumatología, Instituto de Investigación Hospital 12 de Octubre (I+12), Madrid, Spain

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: immune activation, interleukins (IL) and systemic lupus erythematosus (SLE), T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: T cell Biology in Lupus, Vasculitis, Myositis and Other Autoimmunity

Session Type: Abstract Submissions (ACR)

Background/Purpose A-Kinase anchoring Protein AKAP79 associates to and regulates the activity of PKA, PKC and calcineurin, key regulators of T cell activation. We have previously described that AKAP79 is overexpressed in T cells from systemic lupus erythematosus lupus patients and inhibits IL2 transcription in Jurkat T cells (Criado et al., A&R 63 (Suppl10):S916). In the present study, we aim to analyze the effect of AKAP79 levels on IL2 production in SLE and normal T cells and characterize the role of the associations to PKA, PKC and calcineurin in T cell activation and IL2 transcription.

Methods T cells were isolated by negative selection from SLE patients and healthy controls (HC). RNA was purified, retrotranscribed to cDNA and levels of AKAP79 and β-actin transcripts were quantified by quantitative real-time PCR using Sybr Green technology. AKAP79 protein expression was quantified in T cell lysates by ELISA. AKAP79 mutants deficient for association to PKA (ΔPKA-AKAP79), PKC (ΔPKC-AKAP79) and calcineurin (ΔCN-AKAP79) were generated with QuickChange Site Directed Mutagenesis kit and confirmed by sequencing. Jurkat T cells were transduced with dual promoter pRRL-AKAP79/GFP- or control pRRL-GFP-expressing lentiviruses. For functional assays, T cells were stimulated with plate-bound anti-CD3 and soluble anti-CD28 antibodies or PMA/ionomycin. RNA was isolated, IL2 transcripts quantified by quantitative real-time PCR (qPCR) and results calculated as fold change over non-stimulated cell (Mean +/- SEM). Statistical differences between groups were analysed by ANOVA and non-parametric Mann-Whitney U test, using GraphPad Prism software.

Results  IL2 transcription induced by anti-CD3/CD28 stimulation was not significantly different between SLE (n=6) and HC (n=6) T cells. However, a negative correlation between levels of AKAP79 protein and induction of IL2 transcription was found in T cells, regardless of their origin (R2= 0.53, **p=0.0076). This was confirmed in Jurkat T cells by transduction with different amounts of AKAP79 (R2= 0.57, *p=0.03, n= 8). Complementation of anti-CD3/CD28 stimulation by PMA, but not ionomycin, restored IL2 transcription in Jurkat cells overexpressing AKAP79, suggesting that inhibition of PKC by AKAP79 was responsible for the observed reduction of IL2 transcription. Consistent with this interpretation, overexpression of ΔPKC-AKAP79 partially rescued IL2 transcription when compared to WT-AKAP79 but ΔPKA-AKAP79 and ΔCN-AKAP79 had no significant effect (GFP: 11.59 +/- 2.21, AKAP79: 1.67 +/- 0.61, ΔPKC-AKAP79:  4.86 +/- 1.24, ΔPKA-AKAP79: 0.73 +/- 0.29, ΔCN-AKAP79:  0.88 +/- 0.35). Likewise, analysis of the kinetics of Erk activation in response to antiCD3/CD28 showed that Erk activation was blocked by AKAP79 overexpression and was recued by ΔPKC-AKAP79.

Conclusion Overexpression of AKAP79 inhibits IL2 transcription and Erk activation in a PKC-dependent manner. Thus, targeting AKAP79-PKC interaction could provide a therapeutic approach to modulate T cell activation.


Disclosure:

G. Criado,
None;

M. J. Pérez-Lorenzo,
None;

M. Galindo,
None;

J. L. Pablos,
None;

A. Suarez-Fueyo,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/association-of-a-kinase-anchoring-protein-79-akap79-to-pkc-mediates-inhibition-of-il2-transcription-and-erk-activation-in-t-cells/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology